I applaud the company for Learning from their mistakes.

$AVXL What a pro active company Biovie. .incredible.

But this company has something great!

But this company has something great

But the company actually has never seen before wonderful results.

$AVXL this is by far one of the most promising companies that I’ve followed.

$AVXL Anavex is ahead of all the other biotechnology companies now. .

Good luck to all the long holders of both of these outstanding companies!!!!

It’s literally twice as good as the “other company”, without the Brain bleeds.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

New 52 week lows on the daily and this company doesn’t say shit.

Not too shabby for a company with a market cap of $65M!

$NVAX I still believe in the company and its vastly superior vaccine.

NVAX, Novavax is an extremely valuable and attractive Global company for M&A.

Low float, now company has been doing better than ever.

$NVAX please forgive me that i was shorting nvax, such excellent company.

$NVAX I think its a mix of all short burn possible take over (sanofi manager o hara hired, maybe merck, or pfizer) this company has to much potential.

though more confidence in company after he speaks….my outlook at least

$NVAX soon you will be buying 25% discount on the stockprice the big institutions paid for their huge stakes in this company. Amazing.

$NVAX defense company against bio terrorism NVAX.buy.

$BLUE I firmly believe in the positive about this company.

Fantastic company with solid balance sheet and exclusivity contracts being announced left and right.

If you had any one of these 3 diseases you would be all over this company to get treatment.

$BLUE Blue Bird Corporation BLBD is up 36% today.

Great company.

$BLUE I love this company.

$BLUE I’m in again love this company 1hr from headquarters !

$BLUE I used to love this company and had such high hopes.

Now, disregarding product revenue, there is enough cash for the company to enter 2024 with confidence.

$BLUE Every indication from the company was that they would go it alone, with the proceeds of this offering they will be much more viable to achieve success and a good return for shareholders in the long-term.